General Announcement::Board Meeting on November 2, 2017

Issuer & Securities

Issuer/ Manager: GLENMARK PHARMACEUTICALS LIMITED
Securities: GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security: No

Announcement Title: General Announcement
Date &Time of Broadcast: 23-Oct-2017 21:31:35
Status: New
Announcement Sub Title: Board Meeting on November 2, 2017
Announcement Reference: SG171023OTHRLTXY
Submitted By (Co./ Ind. Name): Glenmark Pharmaceuticals Limited
Designation: Company Secretary & Compliance Officer
Effective Date and Time of the event: 23/10/2017 19:00:00
Description (Please provide a detailed description of the event in the box below): We have to inform you that, pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors will be held on Thursday, November 2, 2017, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half year ended September 30, 2017.

Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from September 25, 2017 to November 6, 2017 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Second Quarter and Half year ended September 30, 2017.

Total size =542K